Navigation Links
Why mice don't get cancer of the retina

Humans are more susceptible to developing the eye cancer retinoblastoma than mice because, unlike humans, mice can compensate for the loss of activity of a gene critical to normal retinal development , according to results of a study by investigators at St. Jude Children's Research Hospital. The study, published today in the open access journal BMC Biology, explains why humans with a defective copy of the Retinoblastoma gene RB1 are at high risk of developing cancer of the retina, or retinoblastoma, whereas mice with a similar genetic profile do not develop the cancer.

Stacy Donovan and Brett Schweers from St Jude Children's Research Hospital in Memphis, USA and colleagues from St Jude's and from the University of Tennessee Health Science Center in Memphis, studied the expression of the Retinoblastoma proteins Rb (RB1 in humans), p107 and p130 throughout the development of mouse and human retinae, using molecular amplification and immunolabelling techniques.

Donovan et al. find that p107, Rb and p130 are expressed at different stages in the developing mouse retina, with p107 expressed first and Rb and 130 expressed during the late stages of development. The authors show that, in mutant mouse embryos that do not express Rb at all, the levels of p107 are much higher than in wild-type embryos at the same stage in development. The reverse situation is observed in mutant embryos that do not express p107. This suggests that Rb and p107 compensate for each other in retinal progenitor cells and prevent the deregulated proliferation of the cells that leads to retinoblastoma. By contrast, RB1 is the main protein expressed during retinal development in humans. The protein p107 is only slightly expressed during development and cannot compensate for the lack of RB1, which leads to retinoblastoma.


'"/>

Source:BioMed Central


Page: 1

Related biology news :

1. Penguins waddle but they dont fall down, UH researchers say
2. Nearly half of people who need cholesterol treatment dont get it
3. Study: Paramedics save more lives when they dont follow the rules
4. Even fish dont swim well when theyre young!
5. One-third of adults with diabetes still dont know they have it
6. Survival of the selfless - scientists find cheats dont always prosper
7. Why dont all moles progress to melanoma?
8. New cigarette designs dont offer lower predicted cancer risks
9. Some caterpillers just dont want to grow up
10. Mosquito repellents that emit high-pitched sounds dont prevent bites
11. When your brain talks, your muscles dont always listen

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Why mice don get cancer the retina

(Date:11/4/2009)...ver, BC - Lowly bacteria, it turns out, hold the p...g plants around the world clean up toxic waste on ...cifically RDX, were invented back in World War II ...es. These high-energy compounds are often used to...ersion of TNT. , But with increased knowledge ...
(Date:11/4/2009)...iversity of Oklahoma at Norman has received more t...ng agencies as part of the federal stimulus progra...ceived by OU researchers to $23 million. Thirty-t...h ranging from archaeology to weather. , "The un...approach to matching areasof scholarly excellence ...
(Date:11/4/2009)...DISON, N.J., Oct. 20 Que...ld,s leading provider of diagnostic testing, infor...quarter ended September 30, 2009, income from cont...er diluted share, from $160 million, or $0.81 per ...008, third quarter results were reduced by a $0.03...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17New STR Systems from Promega Comply with Latest DNA Database Standards 14313 1New STR Systems from Promega Comply with Latest DNA Database Standards 14313 2Smoking in Pregnancy Linked to Psychotic Symptoms in Kids 58637 1Smoking in Pregnancy Linked to Psychotic Symptoms in Kids 58637 2Clarian Health Selects Watch4net for Performance Reporting and Automatic Analysis 58635 1Clarian Health Selects Watch4net for Performance Reporting and Automatic Analysis 58635 2
... of an academic medical centers success in fosteri...07 was a banner year for Oregon Health & Science U...tions, more than in any previous year in the unive..., Five new startup companies based on OHSU disco... the total to 33 since 2000 and 64 since the early...
...07 Just in time for Halloween, researchers are re...impact of social stress, in an article scheduled f...gical Psychiatry. As children and adults alike ge...spooky holiday, this study lends a further underst...lon and colleagues at the National Institute of Me...
...bal Solutions, LLC,( http://www.mosaicgs.com ), a ...s and solutions, has just released the Mosaic Inte... ordinary enterprise-class network,video recording...make the,job of video-oriented surveillance dramat...tform takes advantage of IP/Network video surveill...
Other Biology News:OHSU turns innovations into commercial opportunities at record pace 2OHSU turns innovations into commercial opportunities at record pace 3OHSU turns innovations into commercial opportunities at record pace 4OHSU turns innovations into commercial opportunities at record pace 5Social stress + darkness = increased anxiety 2Mosaic Intelligent Video Management System: Video Surveillance Just Got Smarter 2
(Date:11/6/2009)...swire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ON...day announced updated results from a Phase II stud...omas metastatic to the lung in a poster presentati...ociety Meeting held in Miami Beach, Florida, from ...tled "A Phase II Study of Intravenous REOLYSIN (Wi...
(Date:11/5/2009).... 5 GenVec, Inc. (Nasdaq...r the third quarter ended September 30, 2009. GenV...share) for the three months ended September 30, 20...er share) in the comparable quarter of 2008. For t...net loss was $14.1 million ($0.15 per share), comp...
(Date:11/5/2009)..., Nov. 5 ThermoGenesis C...ative products for processing and storing adult st...rter of fiscal 2010. ,, For the quarter ended S...f $5.2 million, a 15 percent increase over revenue... The Company said the key contributors to the grow...
(Date:11/5/2009).... 5 Cepheid (Nasdaq: CP...peaking at the following investor conferences, and... Credit Suisse Healthcare Conferen...mber, 2009 at 10 a.m. Mountain Time, ...and, Tuesday, 1 December, 2009 at ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2
...t to Follow, ROCKVILLE, Md., July 31 Vanda Pharm...cal company focused on the development,and commerc...r central,nervous system disorders, today announce...nded June 30, 2008, on Tuesday, August 5, 2008, be...ease will be disseminated at that,time., Mihael H...
... BioCryst,Pharmaceuticals (Nasdaq: BCRX ) today a...sults will be released on Thursday, August 7, 2008...erence call and Webcast at 8:30 a.m.,Eastern Time ...date on the,Company,s programs. The call will be l...e Officer, and Stuart Grant, BioCryst,s Chief Fina...
...erly revenues of $27.2 million, ATLANTA, July 31 ...cal device and tissue processing company, announce...08 increased 18 percent to,$27.2 million compared ...cluding orthopaedic tissue processing revenues of ...f 2008 and 2007, respectively, total,revenues incr...
Other Biology Technology:Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008 2BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008 2BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008 3CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 2CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 3CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 4CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 5CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 6CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 7CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 8CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 9CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 10CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 11
...as an internal standard for the quantification of ...try. 5-OxoETE is a polyunsaturated keto acid forme... It stimulates cytosolic calcium levels in neutrop...imulates the migration and degranulation of eosino...
...sists of ten double-stranded RNAs, 10, 20, 30, 50,... dsRNA Marker is an ideal size marker for determin...NA band including in the dsRNA Marker is adjusted ...The dsRNA Marker is manufactured for non-denaturin...
...solid. A nucleoside antibiotic that inhibits N-lin...ycosidic protein-carbohydrate linkages. Active in...ngi, and viruses. Inhibits the expression of funct... cells. Also inhibits thrombin-induced Ca 2+ mobi...
...enzymes involved in matrix degradation. Of the six...n exist in soluble form whereas MT-MMPs exist as i...MP also known as MMP14, MMP15, MMP16 respectively ...g them to the cell surface. They have an 8 amino a...
Biology Products: